Belladonna-Injeel S (10d,30d,200d,1000d/1.1ml) 10 D / 1.1 mL Liquid is a Health Canada–registered human drug (DIN 02071762) held by Biologische Heilmittel Heel GmbH, containing Belladonna. Health Canada lists its status as Cancelled Post Market (status date 12 Jul 2001). Nexara Health has matched 21 registrations of Belladonna across 2 other regulated markets.
Health Canada registration
| DIN | 02071762 |
|---|---|
| Brand name | Belladonna-Injeel S (10d,30d,200d,1000d/1.1ml) |
| Active ingredient | Belladonna |
| Strength | 10 D / 1.1 mL |
| Dosage form | Liquid |
| Route | Oral |
| Company | Biologische Heilmittel Heel GmbH |
| Status | Cancelled Post Market — 12 Jul 2001 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Belladonna registered in other markets
21 registrations of the same molecule in 2 national registries outside Canada (first 10 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Netherlands | Belladonna | BOIRON (Messimy) | 4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LM | Uitsluitend apotheek of drogist | EU national register | |
| Netherlands | Belladonna | BOIRON (Messimy) | 4 DH t/m 60 DH#2 CH t/m 200 CH#6 K t/m 100.000 K#1 LM t/m 30 LM | Globuli | Uitsluitend apotheek of drogist | EU national register |
| United States | Belladonna | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Belladonna | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Belladonna | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Belladonna | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Belladonna | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Belladonna | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Belladonna | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Belladonna | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC |
See every manufacturer of Belladonna worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Belladonna-Injeel S (10d,30d,200d,1000d/1.1ml) (DIN 02071762) marketed in Canada?
No. Health Canada lists DIN 02071762 as Cancelled Post Market as of 12 Jul 2001.
Who holds the Canadian licence for this product?
Biologische Heilmittel Heel GmbH is the company of record in the Health Canada Drug Product Database.
Is Belladonna registered outside Canada?
Yes — Nexara Health has matched 21 registrations in 2 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02071762, status date 2001-07-12; national medicine registries: EU national register, FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02071762, status date 2001-07-12; national medicine registries: EU national register, FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02071762, status date 2001-07-12; national medicine registries: EU national register, FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.